Eyeworld

3 March 2018 EW ASCRS NEWS by Liz Hillman EyeWorld Staff Writer by Carl Zeiss Meditec, and "Cataract Innovations," sponsored by Alcon. Unless otherwise noted, the EyeWorld events will take place at the Walter E. Washington Conven- tion Center. For the most up-to- date information about EyeWorld educational events, visit meetings. eyeworld.org. Events and times are subject to change. EW A variety of EyeWorld educational events will be held throughout the ASCRS•ASOA Annual Meeting in Washington, D.C., April 13–16, including offer- ings for CME credit, ASCRS-autho- rized events, and corporate-spon- sored programming. CME programs On April 13, two morning CME events will be "Surpassing Patient Expectations with the Latest Corneal Refractive Options: Results & Cases," and "Optimizing Diagnostic Proto- cols, Combination Therapies, and Modern MIGS for Early to Advanced Glaucoma." Both will have registra- tion and breakfast from 6:00–6:30 a.m., with programming from 6:30–7:30 a.m. "Identifying the Underlying Causes of Ocular Surface Disease for More Accurate Diagnosis and Treat- ment" will take place from 8:00–9:30 a.m. on April 14, with breakfast and registration beginning at 7:30 a.m. "Optimizing Laser Cataract Surgery Applications and Settings to Improve Visual Quality Outcomes" kicks off CME offerings on April 15, with registration and breakfast from 6:00–6:30 a.m. and the pro- gram from 6:30–7:30 a.m. Another Sunday morning CME opportunity, "Phaco Fundamentals: Principles & Pearls for Machine-Specific Settings in Standard and Common Compli- cated Cases," will be offered from 8:30–10:00 a.m. with registration beginning at 8:00 a.m. April 16 will have two CME events. "Four Steps to Increasing Pa- tient Adoption & Surgical Outcomes in Lens-Based Astigmatism Patients" will take place from 6:30–7:30 a.m., with breakfast and registration from 6:00–6:30 a.m. A CME event from 12:00–1:00 p.m. (lunch and registra- tion beginning at 11:30 a.m.) will cover "The Correction of Presbyopia in the Modern Cataract Practice: Optical Principles, Quality of Vision, & Addressing Clinical Challenges." ASCRS-authorized events An ASCRS-authorized event, "The Transformation of MIGS: Coming Soon," supported by an educational grant from Glaukos, will take place on April 15, with registration and a reception beginning at 4:45 p.m. and programming from 5:15–6:15 p.m. Corporate events Several corporate breakfasts will be held on April 14. "New Dimensions in Cataract Surgery—an Education- al and Interactive Event Brought to You By the Alcon Experience Academy," sponsored by Alcon, will be held from 7:00–9:30 a.m. with registration and breakfast beginning at 6:30 a.m. OCULUS is sponsoring "Preoperative Planning to Optimize Cataract and Refractive Outcomes in Challenging Cases, Clinical Use of the Holladay Report on the Pen- tacam for Cataract and Refractive Surgery" from 7:30–9:30 a.m., with registration and breakfast starting at 7:00 a.m. "Complex Cataract Cases, the Simple Truths VI," sponsored by Microsurgical Technology, will run from 8:30–9:30 a.m. on Satur- day with registration and breakfast starting at 8:00 a.m. The program for "New Horizons in Goniotomy," sponsored by New World Medical, will take place from 8:30–9:30 a.m. with registration and breakfast from 8:00–8:30 a.m. "Capsular/Cata- ract Complications: A Video-Based Symposium" sponsored by Epsilon USA, will have programming from 8:30–9:30 a.m., with registration and breakfast beginning at 8:00 a.m. Corporate-sponsored lunch- es on April 14 include "Pearls for Improved Refractive Outcomes with Cataract Surgery," sponsored by Haag-Streit Diagnostics and Haag-Streit USA, from 12:00–1:00 p.m.; registration and lunch begin at 11:30 a.m. Another lunch event beginning at noon (registration and lunch from 11:30 a.m.–12:00 p.m.) is "Posterior to Anterior: Integrating Advanced Diagnostics for the Cata- ract Refractive Practice," sponsored by Carl Zeiss Meditec. Saturday's evening corporate events include "Mastering Supracil- iary MIGS: A Case Study Review," sponsored by Alcon, from 5:30–6:30 p.m., with registration and a recep- tion beginning at 5:00 p.m. April 15 will feature two cor- porate events from 12:00–1:00 p.m. (registration and lunch at 11:30 a.m.) on "Catching the Rising Tide of Refractive: Identifying & Integrating Advanced Technology," sponsored EyeWorld educational offerings return to ASCRS•ASOA Annual Meeting © 2017 Novartis 9/17 US-ORA-17-E-2539 ORA SYSTEM ® PATIENT IMPORTANT PRODUCT INFORMATION CAUTION: Federal (USA) law restricts this device to sale by, or on the order of, a physician. INTENDED USE: The ORA SYSTEM ® uses wavefront aberrometry data in the measurement and analysis of the refractive power of the eye (i.e. sphere, cylinder, and axis measurements) to support cataract surgical procedures. CONTRAINDICATIONS: There are no known contraindications for this device. WARNINGS AND PRECAUTIONS: The following conditions may make it difficult for your doctor to obtain accurate readings using the ORA SYSTEM ® : Patients having progressive retinal pathology such as diabetic retinopathy, macular degeneration, or any other pathology that the physician deems would interfere with patient fixation; Patients having corneal pathology such as Fuchs', EBMD, keratoconus, advanced pterygium impairing the cornea, or any other pathology that the physician deems would interfere with the measurement process; Patients for which the preoperative regimen includes residual viscous substances left on the corneal surface such as lidocaine gel or viscoelastics; Visually significant media opacity, such as prominent floaters or asteroid hyalosis, will either limit or prohibit the measurement process; or Patients having received retro or peribulbar block or any other treatment that impairs their ability to visualize the fixation light. Use of iris hooks during an ORA SYSTEM ® image capture will yield inaccurate measurements. In addition: Significant central corneal irregularities resulting in higher order aberrations might yield inaccurate refractive measurements. Post refractive keratectomy eyes might yield inaccurate refractive measurement. The safety and effectiveness of using the data from the ORA SYSTEM ® have not been established for determining treatments involving higher order aberrations of the eye such as coma and spherical aberrations. The ORA SYSTEM ® is intended for use by qualified health personnel only. Improper use of this device may result in exposure to dangerous voltage or hazardous laser-like radiation exposure. The ORA SYSTEM ® should not be operated in the presence of flammable anesthetics or volatile solvents such as alcohol or benzene, or in locations that present an explosion hazard. ATTENTION: Ask your doctor for more information about the ORA SYSTEM ® and its use in your cataract procedure. SYSTEM® with Verif Eye ® + 100236 US-ORA-17-E-2539_PI EW.indd 1 12/8/17 12:20 PM

• Blank Page
• Blank Page (1)